These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23235)

  • 61. Urinary metabolites of timolol from humans and laboratory animals. Syntheses and beta-adrenergic blocking activities.
    Wasson BK; Scheigetz J; Rooney CS; Hall RA; Share NN; VandenHeuvel WJ; Arison BH; Hensens OD; Ellsworth RL; Tocco DJ
    J Med Chem; 1980 Nov; 23(11):1178-84. PubMed ID: 6109024
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differential response of beta-adrenergic receptor-mediated heart rate and aortic blood flow acceleration to timolol.
    Clifton GD; Chandler MH; Pennell AT; McCoy RA; Harrison MR
    Clin Pharmacol Ther; 1992 Mar; 51(3):296-301. PubMed ID: 1312003
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Beta-Adrenergic blocking agents. 15. 1-Substituted ureidophenoxy-3-amino-2-propanols.
    Smith LH
    J Med Chem; 1977 May; 20(5):705-8. PubMed ID: 16137
    [No Abstract]   [Full Text] [Related]  

  • 64. Beta-adrenoceptor and cardiovascular effects of MJ 13105 (bucindolol) in anesthetized dogs and rats.
    Deitchman D; Perhach JL; Snyder RW
    Eur J Pharmacol; 1980 Feb; 61(3):263-77. PubMed ID: 6102523
    [No Abstract]   [Full Text] [Related]  

  • 65. The duration of effect of SL75212 on an exercise tachycardia [proceedings].
    Balnave K; Neill JD; Russell CJ; Shanks RG; Leahey WJ; Wilson R; Harran DW
    Br J Clin Pharmacol; 1980 Mar; 9(3):297P-298P. PubMed ID: 6102471
    [No Abstract]   [Full Text] [Related]  

  • 66. Comparison of the effect of timolol versus betaxolol ophthalmic on cardiopulmonary exercise performance in healthy volunteers.
    Dickstein K
    Surv Ophthalmol; 1989 Apr; 33 Suppl():457-8; discussion 459-60. PubMed ID: 2749518
    [No Abstract]   [Full Text] [Related]  

  • 67. Effect of beta adrenergic agents on blood vessels of the rat iris. I. Permeability to carbon particles.
    Szalay J; Fliegenspan J; Zaager A; Tobin G; Cross S
    Exp Eye Res; 1980 Sep; 31(3):289-97. PubMed ID: 7428848
    [No Abstract]   [Full Text] [Related]  

  • 68. Novel antihypertensive drug reveals unexpected complexities in beta-adrenoceptor pharmacology.
    Boudier HS; Abbott A
    Trends Pharmacol Sci; 1989 Dec; 10(12):469-71. PubMed ID: 2575812
    [No Abstract]   [Full Text] [Related]  

  • 69. Initial evaluation of transdermal timolol: serum concentrations and beta-blockade.
    Vlasses PH; Ribeiro LG; Rotmensch HH; Bondi JV; Loper AE; Hichens M; Dunlay MC; Ferguson RK
    J Cardiovasc Pharmacol; 1985; 7(2):245-50. PubMed ID: 2581075
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antihypertensive activity of (-) moprolol in man: double-blind comparison of enantiomers.
    Ghirardi P; Grosso F
    J Cardiovasc Pharmacol; 1980; 2(4):471-2. PubMed ID: 6156344
    [No Abstract]   [Full Text] [Related]  

  • 71. Timolol-induced up-regulation of polymorphonuclear leukocyte beta 2-adrenergic receptors in the elderly.
    Zahniser NR; Bier-Laning CM; Gerber JG; Nies AS
    Clin Pharmacol Ther; 1989 May; 45(5):469-75. PubMed ID: 2541960
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Tolerance and side effects during long term treatment of hypertension with debrisoquine.
    Jackson WB
    Aust N Z J Med; 1972 Nov; 2(4):357-65. PubMed ID: 4144623
    [No Abstract]   [Full Text] [Related]  

  • 73. Simplified antihypertensive therapy with pindolol retard.
    Kiowski W; Stumpe KO; Bühler FR
    Eur J Clin Pharmacol; 1982; 21(6):445-9. PubMed ID: 7075649
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.
    Prichard BN
    Br J Clin Pharmacol; 1982 Jan; 13(1):51-60. PubMed ID: 6121573
    [No Abstract]   [Full Text] [Related]  

  • 75. The management of hypertension.
    Prichard BN; Owens CW
    Br J Clin Pharmacol; 1986; 21 Suppl 2(Suppl 2):129S-142S. PubMed ID: 3530297
    [No Abstract]   [Full Text] [Related]  

  • 76. Drug treatment of hypertension.
    Prichard BN
    Drugs; 1988; 35 Suppl 6():40-52. PubMed ID: 3042360
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antihypertensive and beta-adrenoceptor antagonist action of timolol.
    Simon G; Kiowski W; Julius S
    Clin Pharmacol Ther; 1978 Feb; 23(2):152-7. PubMed ID: 23235
    [No Abstract]   [Full Text] [Related]  

  • 78. Relationships among timolol doses, plasma concentrations and beta-adrenoceptor blocking activity.
    Ferguson RK; Vlasses PH; Koplin JR; Holmes GI; Huber P; Demetriades J; Abrams WB
    Br J Clin Pharmacol; 1982 Nov; 14(5):719-25. PubMed ID: 6128021
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of disposition and effect of timolol and propranolol on exercise tachycardia.
    Ishizaki T; Tawara K
    Eur J Clin Pharmacol; 1978 Nov; 14(1):7-14. PubMed ID: 32043
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Beta-blockade, renin and blood-pressure.
    Weber MA; Drayer JI; Laragh JH
    Lancet; 1977 Feb; 1(8007):367-8. PubMed ID: 64892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.